363 related articles for article (PubMed ID: 19885608)
21. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
22. Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer.
Demokan S; Chuang A; Suoğlu Y; Ulusan M; Yalnız Z; Califano JA; Dalay N
Head Neck; 2012 Oct; 34(10):1470-5. PubMed ID: 22106032
[TBL] [Abstract][Full Text] [Related]
23.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
24. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.
Zhang XY; Li M; Sun K; Chen XJ; Meng J; Wu L; Zhang P; Tong X; Jiang WW
Oncotarget; 2015 Jan; 6(1):101-15. PubMed ID: 25575809
[TBL] [Abstract][Full Text] [Related]
26. MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.
Pattani KM; Soudry E; Glazer CA; Ochs MF; Wang H; Schussel J; Sun W; Hennessey P; Mydlarz W; Loyo M; Demokan S; Smith IM; Califano JA
PLoS One; 2012; 7(9):e45534. PubMed ID: 23029077
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
30. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
31. Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies.
Shi H; Chen X; Lu C; Gu C; Jiang H; Meng R; Niu X; Huang Y; Lu M
PLoS One; 2015; 10(4):e0122302. PubMed ID: 25835498
[TBL] [Abstract][Full Text] [Related]
32. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
Puri SK; Si L; Fan CY; Hanna E
Am J Otolaryngol; 2005; 26(1):12-7. PubMed ID: 15635575
[TBL] [Abstract][Full Text] [Related]
33. PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.
Bertonha FB; Barros Filho Mde C; Kuasne H; Dos Reis PP; da Costa Prando E; Muñoz JJ; Roffé M; Hajj GN; Kowalski LP; Rainho CA; Rogatto SR
Mol Oncol; 2015 Feb; 9(2):450-62. PubMed ID: 25454821
[TBL] [Abstract][Full Text] [Related]
34. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
[TBL] [Abstract][Full Text] [Related]
35. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.
Bennett KL; Romigh T; Eng C
PLoS One; 2009 Sep; 4(9):e6931. PubMed ID: 19742317
[TBL] [Abstract][Full Text] [Related]
36. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
37. Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.
Alsofyani AA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Elaimi A; Al-Qahtani MH; Abuzenadah AM; Dallol A
J Appl Genet; 2017 Nov; 58(4):459-465. PubMed ID: 28812223
[TBL] [Abstract][Full Text] [Related]
38. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR.
Wong TS; Man MW; Lam AK; Wei WI; Kwong YL; Yuen AP
Eur J Cancer; 2003 Sep; 39(13):1881-7. PubMed ID: 12932666
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic and genetic alterations affect the WWOX gene in head and neck squamous cell carcinoma.
Ekizoglu S; Bulut P; Karaman E; Kilic E; Buyru N
PLoS One; 2015; 10(1):e0115353. PubMed ID: 25612104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
